Originally published3 Nov 1998https://doi.org/10.1161/01.CIR.98.18.1937Circulation. 1998;98:1937–1942 The purpose of this presentation is 2-fold: to tell the ...
HTx remains the surgical procedure of choice for eligible patients with severe advanced HF, 4,5 with little change in the number of transplants performed yearly over the past decade. The body of ...
*Adjusted by: age, gender, stage, tumour type, intention of treatment, CT type and duration, prophylactic G-CSF use, G-CSF use within 72h after CT, baseline biochemistry.